vs
MURPHY OIL CORP（MUR）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是MURPHY OIL CORP的1.0倍（$622.0M vs $613.1M），Royalty Pharma plc净利率更高（34.4% vs 1.9%，领先32.5%），Royalty Pharma plc同比增速更快（4.8% vs -8.4%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -12.2%）
墨菲石油公司是一家美国能源企业，核心业务为油气勘探开发，总部位于得克萨斯州休斯敦，在全球能源勘探领域拥有成熟的业务布局与行业经验。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MUR vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.0倍
$613.1M
营收增速更快
RPRX
高出13.2%
-8.4%
净利率更高
RPRX
高出32.5%
1.9%
两年增速更快
RPRX
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $613.1M | $622.0M |
| 净利润 | $11.9M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 9.7% | 62.4% |
| 净利率 | 1.9% | 34.4% |
| 营收同比 | -8.4% | 4.8% |
| 净利润同比 | -76.3% | 2.9% |
| 每股收益（稀释后） | $0.08 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MURRPRX
| Q4 25 | $613.1M | $622.0M | ||
| Q3 25 | $721.0M | $609.3M | ||
| Q2 25 | $683.0M | $578.7M | ||
| Q1 25 | $672.7M | $568.2M | ||
| Q4 24 | $669.6M | $593.6M | ||
| Q3 24 | $753.2M | $564.7M | ||
| Q2 24 | $801.0M | $537.3M | ||
| Q1 24 | $794.8M | $568.0M |
净利润MURRPRX
| Q4 25 | $11.9M | $214.2M | ||
| Q3 25 | $-3.0M | $288.2M | ||
| Q2 25 | $22.3M | $30.2M | ||
| Q1 25 | $73.0M | $238.3M | ||
| Q4 24 | $50.4M | $208.2M | ||
| Q3 24 | $139.1M | $544.0M | ||
| Q2 24 | $127.7M | $102.0M | ||
| Q1 24 | $90.0M | $4.8M |
毛利率MURRPRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 99.6% | — | ||
| Q1 24 | 100.0% | — |
营业利润率MURRPRX
| Q4 25 | 9.7% | 62.4% | ||
| Q3 25 | 0.8% | 70.1% | ||
| Q2 25 | 13.5% | 36.3% | ||
| Q1 25 | 21.4% | 94.0% | ||
| Q4 24 | 12.7% | 60.9% | ||
| Q3 24 | 23.8% | — | ||
| Q2 24 | 23.0% | 50.2% | ||
| Q1 24 | 19.4% | -13.0% |
净利率MURRPRX
| Q4 25 | 1.9% | 34.4% | ||
| Q3 25 | -0.4% | 47.3% | ||
| Q2 25 | 3.3% | 5.2% | ||
| Q1 25 | 10.9% | 41.9% | ||
| Q4 24 | 7.5% | 35.1% | ||
| Q3 24 | 18.5% | 96.3% | ||
| Q2 24 | 15.9% | 19.0% | ||
| Q1 24 | 11.3% | 0.8% |
每股收益（稀释后）MURRPRX
| Q4 25 | $0.08 | $0.49 | ||
| Q3 25 | $-0.02 | $0.67 | ||
| Q2 25 | $0.16 | $0.07 | ||
| Q1 25 | $0.50 | $0.55 | ||
| Q4 24 | $0.35 | $0.46 | ||
| Q3 24 | $0.93 | $1.21 | ||
| Q2 24 | $0.83 | $0.23 | ||
| Q1 24 | $0.59 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $377.2M | $618.7M |
| 总债务越低越好 | $1.4B | $9.0B |
| 股东权益账面价值 | $5.1B | $9.7B |
| 总资产 | $9.8B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.27× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MURRPRX
| Q4 25 | $377.2M | $618.7M | ||
| Q3 25 | $426.0M | $938.9M | ||
| Q2 25 | $379.6M | $631.9M | ||
| Q1 25 | $392.9M | $1.1B | ||
| Q4 24 | $423.6M | $929.0M | ||
| Q3 24 | $271.2M | $950.1M | ||
| Q2 24 | $333.6M | $1.8B | ||
| Q1 24 | $323.4M | $843.0M |
总债务MURRPRX
| Q4 25 | $1.4B | $9.0B | ||
| Q3 25 | $1.4B | $8.9B | ||
| Q2 25 | $1.5B | $8.0B | ||
| Q1 25 | $1.5B | $7.6B | ||
| Q4 24 | $1.3B | $7.6B | ||
| Q3 24 | $1.3B | $7.6B | ||
| Q2 24 | $1.3B | $7.6B | ||
| Q1 24 | $1.3B | $6.1B |
股东权益MURRPRX
| Q4 25 | $5.1B | $9.7B | ||
| Q3 25 | $5.1B | $9.6B | ||
| Q2 25 | $5.2B | $9.5B | ||
| Q1 25 | $5.1B | $9.8B | ||
| Q4 24 | $5.2B | $10.3B | ||
| Q3 24 | $5.2B | $10.3B | ||
| Q2 24 | $5.3B | $9.8B | ||
| Q1 24 | $5.3B | $9.9B |
总资产MURRPRX
| Q4 25 | $9.8B | $19.6B | ||
| Q3 25 | $9.7B | $19.3B | ||
| Q2 25 | $9.8B | $18.3B | ||
| Q1 25 | $9.8B | $17.6B | ||
| Q4 24 | $9.7B | $18.2B | ||
| Q3 24 | $9.7B | $18.0B | ||
| Q2 24 | $9.9B | $17.7B | ||
| Q1 24 | $9.7B | $16.1B |
负债/权益比MURRPRX
| Q4 25 | 0.27× | 0.92× | ||
| Q3 25 | 0.28× | 0.93× | ||
| Q2 25 | 0.28× | 0.84× | ||
| Q1 25 | 0.29× | 0.78× | ||
| Q4 24 | 0.25× | 0.74× | ||
| Q3 24 | 0.24× | 0.74× | ||
| Q2 24 | 0.24× | 0.78× | ||
| Q1 24 | 0.25× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $249.6M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 20.92× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MURRPRX
| Q4 25 | $249.6M | $827.1M | ||
| Q3 25 | $339.4M | $702.6M | ||
| Q2 25 | $358.1M | $364.0M | ||
| Q1 25 | $300.7M | $596.1M | ||
| Q4 24 | $433.6M | $742.5M | ||
| Q3 24 | $429.0M | $703.6M | ||
| Q2 24 | $467.7M | $658.2M | ||
| Q1 24 | $398.8M | $664.6M |
现金转化率MURRPRX
| Q4 25 | 20.92× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | 16.06× | 12.06× | ||
| Q1 25 | 4.12× | 2.50× | ||
| Q4 24 | 8.61× | 3.57× | ||
| Q3 24 | 3.08× | 1.29× | ||
| Q2 24 | 3.66× | 6.45× | ||
| Q1 24 | 4.43× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MUR
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
